HEADER SERINE PROTEASE 16-MAY-97 1MTV TITLE FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRYPSIN; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.21.4 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913 KEYWDS HYDROLASE, SERINE PROTEASE EXPDTA X-RAY DIFFRACTION AUTHOR M.T.STUBBS REVDAT 3 23-OCT-24 1MTV 1 REMARK LINK REVDAT 2 24-FEB-09 1MTV 1 VERSN REVDAT 1 12-NOV-97 1MTV 0 JRNL AUTH M.T.STUBBS,R.HUBER,W.BODE JRNL TITL CRYSTAL STRUCTURES OF FACTOR XA SPECIFIC INHIBITORS IN JRNL TITL 2 COMPLEX WITH TRYPSIN: STRUCTURAL GROUNDS FOR INHIBITION OF JRNL TITL 3 FACTOR XA AND SELECTIVITY AGAINST THROMBIN. JRNL REF FEBS LETT. V. 375 103 1995 JRNL REFN ISSN 0014-5793 JRNL PMID 7498454 JRNL DOI 10.1016/0014-5793(95)01190-P REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.J.BURGERING,L.P.ORBONS,A.VAN DER DOELEN,J.MULDERS, REMARK 1 AUTH 2 H.J.THEUNISSEN,P.D.GROOTENHUIS,W.BODE,R.HUBER,M.T.STUBBS REMARK 1 TITL THE SECOND KUNITZ DOMAIN OF HUMAN TISSUE FACTOR PATHWAY REMARK 1 TITL 2 INHIBITOR. CLONING, STRUCTURE DETERMINATION AND INTERACTION REMARK 1 TITL 3 WITH FACTOR XA REMARK 1 REF J.MOL.BIOL. V. 269 395 1997 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.VAN DE LOCHT,M.T.STUBBS,W.BODE,T.FRIEDRICH, REMARK 1 AUTH 2 C.BOLLSCHWEILER,W.HOFFKEN,R.HUBER REMARK 1 TITL THE ORNITHODORIN-THROMBIN CRYSTAL STRUCTURE, A KEY TO THE REMARK 1 TITL 2 TAP ENIGMA? REMARK 1 REF EMBO J. V. 15 6011 1996 REMARK 1 REFN ISSN 0261-4189 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.T.STUBBS REMARK 1 TITL STRUCTURAL ASPECTS OF FACTOR XA INHIBITION REMARK 1 REF CURR.PHARM.DES. V. 2 543 1996 REMARK 1 REFN ISSN 1381-6128 REMARK 1 REFERENCE 4 REMARK 1 AUTH H.BRANDSTETTER,A.KUHNE,W.BODE,R.HUBER,W.VON DER SAAL, REMARK 1 AUTH 2 K.WIRTHENSOHN,R.A.ENGH REMARK 1 TITL X-RAY STRUCTURE OF ACTIVE SITE-INHIBITED CLOTTING FACTOR XA. REMARK 1 TITL 2 IMPLICATIONS FOR DRUG DESIGN AND SUBSTRATE RECOGNITION REMARK 1 REF J.BIOL.CHEM. V. 271 29988 1996 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 5 REMARK 1 AUTH K.PADMANABHAN,K.P.PADMANABHAN,A.TULINSKY,C.H.PARK,W.BODE, REMARK 1 AUTH 2 R.HUBER,D.T.BLANKENSHIP,A.D.CARDIN,W.KISIEL REMARK 1 TITL STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 232 947 1993 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 6 REMARK 1 AUTH D.TURK,J.STURZEBECHER,W.BODE REMARK 1 TITL GEOMETRY OF BINDING OF THE N ALPHA-TOSYLATED PIPERIDIDES OF REMARK 1 TITL 2 M-AMIDINO-, P-AMIDINO-AND P-GUANIDINO PHENYLALANINE TO REMARK 1 TITL 3 THROMBIN AND TRYPSIN. X-RAY CRYSTAL STRUCTURES OF THEIR REMARK 1 TITL 4 TRYPSIN COMPLEXES AND MODELING OF THEIR THROMBIN COMPLEXES REMARK 1 REF FEBS LETT. V. 287 133 1991 REMARK 1 REFN ISSN 0014-5793 REMARK 1 REFERENCE 7 REMARK 1 AUTH W.BODE,D.TURK,J.STURZEBECHER REMARK 1 TITL GEOMETRY OF BINDING OF THE BENZAMIDINE-AND ARGININE-BASED REMARK 1 TITL 2 INHIBITORS N REMARK 1 TITL 3 ALPHA-(2-NAPHTHYL-SULPHONYL-GLYCYL) REMARK 1 TITL 4 -DL-P-AMIDINOPHENYLALANYL-PIPERIDINE (NAPAP) AND REMARK 1 TITL 5 (2R,4R)-4-METHYL-1-[N REMARK 1 TITL 6 ALPHA-(3-METHYL-1,2,3,4-TETRAHYDRO-8-QUINOLINESULPHONYL) REMARK 1 TITL 7 -L-ARGINYL]-2-PIPERIDINE TO CARBOXYLIC ACID (MQPA) HUMAN REMARK 1 TITL 8 ALPHA-THROMBIN. X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE REMARK 1 TITL 9 NAPAP-TRYPSIN COMPLEX AND MODELING OF NAPAP-THROMBIN AND REMARK 1 TITL10 MQPA-THROMBIN REMARK 1 REF EUR.J.BIOCHEM. V. 193 175 1990 REMARK 1 REFN ISSN 0014-2956 REMARK 1 REFERENCE 8 REMARK 1 AUTH H.D.BARTUNIK,L.J.SUMMERS,H.H.BARTSCH REMARK 1 TITL CRYSTAL STRUCTURE OF BOVINE BETA-TRYPSIN AT 1.5 A RESOLUTION REMARK 1 TITL 2 IN A CRYSTAL FORM WITH LOW MOLECULAR PACKING DENSITY. ACTIVE REMARK 1 TITL 3 SITE GEOMETRY, ION PAIRS AND SOLVENT STRUCTURE REMARK 1 REF J.MOL.BIOL. V. 210 813 1989 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 9 REMARK 1 AUTH W.BODE,P.SCHWAGER REMARK 1 TITL THE REFINED CRYSTAL STRUCTURE OF BOVINE BETA-TRYPSIN AT 1.8 REMARK 1 TITL 2 A RESOLUTION. II. CRYSTALLOGRAPHIC REFINEMENT, CALCIUM REMARK 1 TITL 3 BINDING SITE, BENZAMIDINE BINDING SITE AND ACTIVE SITE AT PH REMARK 1 TITL 4 7.0 REMARK 1 REF J.MOL.BIOL. V. 98 693 1975 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.4 REMARK 3 NUMBER OF REFLECTIONS : 13599 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 61.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 461 REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1629 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 244 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : 8.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.780 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.210 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1MTV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000175163. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : MAR-95 REMARK 200 TEMPERATURE (KELVIN) : 287 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14594 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.03700 REMARK 200 R SYM (I) : 0.03700 REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : 0.14000 REMARK 200 R SYM FOR SHELL (I) : 0.14000 REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M AMMONIUM SULFATE, PH 7.0, 20% PEG REMARK 280 8000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.56667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 73.13333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 73.13333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 36.56667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 71 -69.91 -127.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 480 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 70 OE1 REMARK 620 2 ASN A 72 O 94.0 REMARK 620 3 VAL A 75 O 172.7 83.4 REMARK 620 4 GLU A 80 OE2 93.7 134.3 83.4 REMARK 620 5 HOH A 711 O 77.3 115.4 110.0 110.2 REMARK 620 6 HOH A 714 O 87.9 76.5 84.8 58.9 161.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 480 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BX3 A 999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MTS RELATED DB: PDB REMARK 900 RELATED ID: 1MTU RELATED DB: PDB REMARK 900 RELATED ID: 1MTW RELATED DB: PDB DBREF 1MTV A 16 245 UNP P00760 TRY1_BOVIN 21 243 SEQRES 1 A 223 ILE VAL GLY GLY TYR THR CYS GLY ALA ASN THR VAL PRO SEQRES 2 A 223 TYR GLN VAL SER LEU ASN SER GLY TYR HIS PHE CYS GLY SEQRES 3 A 223 GLY SER LEU ILE ASN SER GLN TRP VAL VAL SER ALA ALA SEQRES 4 A 223 HIS CYS TYR LYS SER GLY ILE GLN VAL ARG LEU GLY GLU SEQRES 5 A 223 ASP ASN ILE ASN VAL VAL GLU GLY ASN GLU GLN PHE ILE SEQRES 6 A 223 SER ALA SER LYS SER ILE VAL HIS PRO SER TYR ASN SER SEQRES 7 A 223 ASN THR LEU ASN ASN ASP ILE MET LEU ILE LYS LEU LYS SEQRES 8 A 223 SER ALA ALA SER LEU ASN SER ARG VAL ALA SER ILE SER SEQRES 9 A 223 LEU PRO THR SER CYS ALA SER ALA GLY THR GLN CYS LEU SEQRES 10 A 223 ILE SER GLY TRP GLY ASN THR LYS SER SER GLY THR SER SEQRES 11 A 223 TYR PRO ASP VAL LEU LYS CYS LEU LYS ALA PRO ILE LEU SEQRES 12 A 223 SER ASP SER SER CYS LYS SER ALA TYR PRO GLY GLN ILE SEQRES 13 A 223 THR SER ASN MET PHE CYS ALA GLY TYR LEU GLU GLY GLY SEQRES 14 A 223 LYS ASP SER CYS GLN GLY ASP SER GLY GLY PRO VAL VAL SEQRES 15 A 223 CYS SER GLY LYS LEU GLN GLY ILE VAL SER TRP GLY SER SEQRES 16 A 223 GLY CYS ALA GLN LYS ASN LYS PRO GLY VAL TYR THR LYS SEQRES 17 A 223 VAL CYS ASN TYR VAL SER TRP ILE LYS GLN THR ILE ALA SEQRES 18 A 223 SER ASN HET CA A 480 1 HET BX3 A 999 34 HETNAM CA CALCIUM ION HETNAM BX3 (+)-2-[4-[(-1-ACETIMIDOYL-4-PIPERIDINYL)OXY]-3-(7- HETNAM 2 BX3 AMIDINO-2-NAPHTHYL)PROPIONIC ACID HETSYN BX3 BX5633 FORMUL 2 CA CA 2+ FORMUL 3 BX3 C27 H30 N4 O3 FORMUL 4 HOH *244(H2 O) HELIX 1 1 ALA A 56 CYS A 58 5 3 HELIX 2 2 ASP A 165 ALA A 171 1 7 HELIX 3 3 VAL A 231 ASN A 233 5 3 HELIX 4 4 VAL A 235 ALA A 243 1 9 SHEET 1 A 7 GLN A 81 SER A 84 0 SHEET 2 A 7 GLN A 64 LEU A 67 -1 N LEU A 67 O GLN A 81 SHEET 3 A 7 GLN A 30 ASN A 34 -1 N ASN A 34 O GLN A 64 SHEET 4 A 7 HIS A 40 ASN A 48 -1 N GLY A 44 O VAL A 31 SHEET 5 A 7 TRP A 51 SER A 54 -1 N VAL A 53 O SER A 45 SHEET 6 A 7 MET A 104 LEU A 108 -1 N ILE A 106 O VAL A 52 SHEET 7 A 7 ALA A 85 VAL A 90 -1 N ILE A 89 O LEU A 105 SHEET 1 B 6 LYS A 156 PRO A 161 0 SHEET 2 B 6 GLN A 135 GLY A 140 -1 N GLY A 140 O LYS A 156 SHEET 3 B 6 PRO A 198 CYS A 201 -1 N VAL A 200 O LEU A 137 SHEET 4 B 6 LYS A 204 TRP A 215 -1 N GLY A 211 O VAL A 199 SHEET 5 B 6 GLY A 226 LYS A 230 -1 N THR A 229 O ILE A 212 SHEET 6 B 6 MET A 180 ALA A 183 -1 N ALA A 183 O GLY A 226 SSBOND 1 CYS A 22 CYS A 157 1555 1555 2.03 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 3 CYS A 128 CYS A 232 1555 1555 2.03 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.03 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.03 LINK OE1 GLU A 70 CA CA A 480 1555 1555 2.42 LINK O ASN A 72 CA CA A 480 1555 1555 2.33 LINK O VAL A 75 CA CA A 480 1555 1555 2.18 LINK OE2 GLU A 80 CA CA A 480 1555 1555 3.07 LINK CA CA A 480 O HOH A 711 1555 1555 2.19 LINK CA CA A 480 O HOH A 714 1555 1555 2.28 SITE 1 AC1 6 GLU A 70 ASN A 72 VAL A 75 GLU A 80 SITE 2 AC1 6 HOH A 711 HOH A 714 SITE 1 AC2 19 ASN A 97 THR A 98 LEU A 99 SER A 127 SITE 2 AC2 19 CYS A 128 GLN A 175 ASP A 189 SER A 190 SITE 3 AC2 19 SER A 195 TRP A 215 GLY A 216 GLY A 219 SITE 4 AC2 19 GLY A 226 LYS A 230 HOH A 416 HOH A 723 SITE 5 AC2 19 HOH A 901 HOH A 919 HOH A1347 CRYST1 54.800 54.800 109.700 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018248 0.010536 0.000000 0.00000 SCALE2 0.000000 0.021071 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009116 0.00000